BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 34200413)

  • 1. Lung Transplantation, Pulmonary Endothelial Inflammation, and Ex-Situ Lung Perfusion: A Review.
    Forgie KA; Fialka N; Freed DH; Nagendran J
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes.
    Hsin MK; Zamel R; Cypel M; Wishart D; Han B; Keshavjee S; Liu M
    Ann Surg; 2018 Jan; 267(1):196-197. PubMed ID: 29240608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism.
    Forgie KA; Fialka N; Buchko M; Himmat S; Hatami S; Qi X; Wang X; Buswell KM; Edgar R; Freed DH; Nagendran J
    J Vis Exp; 2022 Feb; (180):. PubMed ID: 35225272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(5):1-47. PubMed ID: 23074408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednisolone as preservation additive prevents from ischemia reperfusion injury in a rat model of orthotopic lung transplantation.
    Paulus P; Holfeld J; Urbschat A; Mutlak H; Ockelmann PA; Tacke S; Zacharowski K; Reissig C; Stay D; Scheller B
    PLoS One; 2013; 8(8):e73298. PubMed ID: 24009745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First experience with ex vivo lung perfusion for initially discarded donor lungs in the Netherlands: a single-centre study.
    Zhang ZL; van Suylen V; van Zanden JE; Van De Wauwer C; Verschuuren EAM; van der Bij W; Erasmus ME
    Eur J Cardiothorac Surg; 2019 May; 55(5):920-926. PubMed ID: 30496383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary graft dysfunction: pathophysiology to guide new preventive therapies.
    Shaver CM; Ware LB
    Expert Rev Respir Med; 2017 Feb; 11(2):119-128. PubMed ID: 28074663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.
    Iske J; Hinze CA; Salman J; Haverich A; Tullius SG; Ius F
    Am J Transplant; 2021 Dec; 21(12):3831-3839. PubMed ID: 34355495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
    Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
    Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged Cold Ischemia Induces Necroptotic Cell Death in Ischemia-Reperfusion Injury and Contributes to Primary Graft Dysfunction after Lung Transplantation.
    Wang X; O'Brien ME; Yu J; Xu C; Zhang Q; Lu S; Liang L; An X; McDyer JF; Mallampalli RK
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):244-256. PubMed ID: 30742487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of primary graft dysfunction using cytokine adsorption during organ preservation and after lung transplantation.
    Ghaidan H; Stenlo M; Niroomand A; Mittendorfer M; Hirdman G; Gvazava N; Edström D; Silva IAN; Broberg E; Hallgren O; Olm F; Wagner DE; Pierre L; Hyllén S; Lindstedt S
    Nat Commun; 2022 Jul; 13(1):4173. PubMed ID: 35882835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation solution for lung transplantation.
    Okada Y; Kondo T
    Gen Thorac Cardiovasc Surg; 2009 Dec; 57(12):635-9. PubMed ID: 20013097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion.
    Boffini M; Ricci D; Bonato R; Fanelli V; Attisani M; Ribezzo M; Solidoro P; Del Sorbo L; Ranieri VM; Rinaldi M
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):789-93. PubMed ID: 25061216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo lung perfusion for prompt recovery from primary graft dysfunction after lung transplantation.
    Matsubara K; Miyoshi K; Kawana S; Kubo Y; Shimizu D; Tomioka Y; Shiotani T; Yamamoto H; Tanaka S; Kurosaki T; Ohara T; Okazaki M; Sugimoto S; Matsukawa A; Toyooka S
    J Heart Lung Transplant; 2024 Feb; 43(2):284-292. PubMed ID: 37852513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation.
    Jenkins JA; Verdiner R; Omar A; Farina JM; Wilson R; D'Cunha J; Reck Dos Santos PA
    Front Immunol; 2024; 15():1341675. PubMed ID: 38380332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary graft dysfunction.
    Suzuki Y; Cantu E; Christie JD
    Semin Respir Crit Care Med; 2013 Jun; 34(3):305-319. PubMed ID: 23821506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of sex-based differences in clinical and molecular responses to ischemia reperfusion after lung transplantation.
    Chacon-Alberty L; Ye S; Daoud D; Frankel WC; Virk H; Mase J; Hochman-Mendez C; Li M; Sampaio LC; Taylor DA; Loor G
    Respir Res; 2021 Dec; 22(1):318. PubMed ID: 34937545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary graft dysfunction after lung transplantation.
    Hunt ML; Cantu E
    Curr Opin Organ Transplant; 2023 Jun; 28(3):180-186. PubMed ID: 37053083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local complement activation is associated with primary graft dysfunction after lung transplantation.
    Kulkarni HS; Ramphal K; Ma L; Brown M; Oyster M; Speckhart KN; Takahashi T; Byers DE; Porteous MK; Kalman L; Hachem RR; Rushefski M; McPhatter J; Cano M; Kreisel D; Scavuzzo M; Mittler B; Cantu E; Pilely K; Garred P; Christie JD; Atkinson JP; Gelman AE; Diamond JM
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32750037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.